Forbion — HyperSinc

General InformationForbion is a European deep-tech venture capital firm founded in 2014 with approximately 50-100+ employees focused on biology, physics, and engineering investments.

Funding & FinancialsForbion has raised multiple funds exceeding €500M+ in assets under management across its vehicle series, making it one of Europe's leading deep-tech VCs.

Leadership & TeamFounded and led by experienced deep-tech venture investors with backgrounds in life sciences and technology; specific CEO details require current verification.

Recent ActivityForbion continues to actively deploy capital across portfolio companies in synthetic biology, biotech, and advanced materials, with regular announcements of new investments and exits.

Highlights

Total Raised

—

Latest Round

—

Stage

Growth

deep-tech

Employees

51-200

Founded 2014

Headquarters

—

News Coverage

2 articles

Last: 1mo ago

Talent Signals

—

SEC Filings

—

News Coverage 2

Deep1mo ago

Memento Medicines launches with $93M to fix retinal disease vasculature

Memento Medicines raised $93M Series A to advance a bispecific antibody that simultaneously activates Tie2 and blocks VEGF, a dual mechanism no approved retinal therapy currently uses.

Deep1mo ago

Memento launches $93M bispecific bet against retinal disease standard

Memento Medicines raised $93M to develop MMT-205, a dual-mechanism antibody challenging anti-VEGF monotherapy dominance in nAMD and DME markets worth billions annually.

Similar Companies 6

LARGO CLEAN ENERGY CORP.TREADSTONE TECHNOLOGIES, INC.QUINO ENERGY INC MUGRID ANALYTICS LONG HILL FUNDS FW1, LLC DAIRYLAND POWER COOPERATIVEPublic